RESULTS
7 matchesFluoRok Raises $30m (£22.8m) Series A to Scale HF-Free Fluorochemical Manufacturing
FluoRok, a UK company building a novel manufacturing platform for fluorochemicals that bypasses the need for highly hazardous hydrogen fluoride (HF), has closed an oversubscribed $30m (£22.8m) Series…
Lutetium Lu 177 Vipivotide Tetraxetan Yields No Responses in PSMA+ ccRCC
Praful Ravi, MB, BChir, MRCP, discusses the LASER futility readout, PSMA heterogeneity in clear cell RCC, and next steps for radiopharmaceuticals.
ICYMI: FDA Clears First DNA Immunotherapy for Rare Airway Disease
WASHINGTON, D.C. — In case you missed it, the U.S. Food and Drug Administration granted accelerated approval last week to Inovio Pharmaceuticals’ Voceryq, the first plasmid DNA-based immunotherapy…
Madrigal Expands Rezdiffra Evidence With 12,000-Patient Study
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals Inc. (Nasdaq: MDGL) will present new clinical and real-world research on its liver disease treatment Rezdiffra at a medical conference in Denver beginning…
VETS Grant Recipients Show Sustained Improvement at One Year in Stanford Medicine Magnesium-Ibogaine Follow-Up
/PRNewswire-PRWeb/ -- Veterans Exploring Treatment Solutions (VETS) today highlighted a Translational Psychiatry study showing that improvements in disability,...
Practice Transitions Group Represents Dr. Shel Wellness & Aesthetics Center in Sale to Bios Wellness Clinics
/PRNewswire-PRWeb/ -- Practice Transitions Group (PTG) served as the sell-side advisor for Houston-based Dr. Shel Wellness & Aesthetics Center in its sale to...
Global biopharma company invests in major Oxfordshire research centre
Vertex Pharmaceuticals plans to build a 155,000 sq ft centre at Harwell Campus.